Back to search

University of Patras

Αποτελέσματα της εξάλειψης των Β λεμφοκυττάρων σε ασθενείς με συστηματικό ερυθηματώδη λύκο

Abstract

dc:description

The aim of this study was to evaluate the effectiveness and safety of B cell depletion [RTX] therapy in patients with SLE who were refractory to standard treatment. We analyzed 38 cases of 34 patients who were treated with RΤΧ. Such cases included lupus nephritis (n = 11), arthritis (n = 7), neuropsychiatric involvement (n = 7), hematological abnormalities (n = 5), pulmonary involvement (n = 4), mucocutaneous involvement (n = 5), vasculitis in 5 patients and 1 case of TTP, 1 case of lupoid hepatitis and 1 case of hemophagocytic syndrome.Patients with lupus nephritis had proteinuria (range: 1,000-11,5000mg/24h). Proteinuria decreased 1 month after RTX administration (Μean ± S.D.: 1693mg/24h ± 1653mg/24h, p = 0.06). Similarly, the difference was numerically but not statistically significant at 6 months after RTX administration (p = 0.08, Μean ± S.D.: 1550mg/24h ± 2025mg/24h). Nevertheless, the difference became statistically significant at 12 months after RTX administration (Μean ± S.D.: 954mg/24h ± 1062mg/24h, p = 0.01).Renal function determined by serum creatinine levels remained stable at 12 months after RTX administration. The overall therapeutic response rate in patients with lupus nephritis was almost 82%. Clinical response rate was 100% in patients with arthritis, vasculitis, hematological disorders and neuropsychiatric involvement. Response rates were 80% in patients with mucocutaneous involvement and 75% in patients with lung involvement. The follow up of treated patients ranged from 1 - 15 years. Relapses occurred in 10/38 cases and the earliest one was observed at 6 months following RTX administration in 4 patients. RTX was generally safe and well tolerated. Finally, there was a decrease of the mean dose of daily corticosteroids achieving statistical significance at 6 months (p = 0.0002) and at 12 months (p = 0.0003) after RTX administration.

Degree

thesis:*
Grantor dc:publisher
University of Patras
Year dc:date
2019

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Staveri, Chrysanthi
  • Στάβερη, Χρυσάνθη

Subjects

dc:subject × 8

Rights

dc:rights
Statement dc:rights
  • BY_NC_ND
Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/46500

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Staveri, Chrysanthi; Στάβερη, Χρυσάνθη. Αποτελέσματα της εξάλειψης των Β λεμφοκυττάρων σε ασθενείς με συστηματικό ερυθηματώδη λύκο. University of Patras, 2019. http://hdl.handle.net/10442/hedi/46500